Owens & Minor (NYSE:OMI) Reaches New 52-Week Low - Time to Sell?

Owens & Minor, Inc. (NYSE:OMI - Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The company traded as low as $11.75 and last traded at $12.52, with a volume of 261694 shares changing hands. The stock had previously closed at $13.36.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on OMI shares. StockNews.com lowered Owens & Minor from a "buy" rating to a "hold" rating in a report on Monday, August 26th. Robert W. Baird decreased their price target on shares of Owens & Minor from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Tuesday, July 16th. Citigroup upgraded Owens & Minor from a "neutral" rating to a "buy" rating and reduced their price objective for the stock from $24.00 to $19.00 in a research report on Friday, July 19th. Barclays lowered their price objective on Owens & Minor from $23.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Monday, August 5th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Owens & Minor from $22.00 to $18.00 and set an "underweight" rating on the stock in a research note on Wednesday, August 21st. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $20.00.

Owens & Minor Stock Down 10.2 %

The firm has a fifty day moving average price of $14.62 and a 200 day moving average price of $16.28. The firm has a market capitalization of $925.20 million, a price-to-earnings ratio of -21.43, a P/E/G ratio of 0.41 and a beta of 0.41. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.17.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings data on Friday, August 2nd. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.03. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The firm had revenue of $2.67 billion during the quarter, compared to analyst estimates of $2.65 billion. During the same period last year, the company earned $0.18 earnings per share. The company's revenue was up 4.2% on a year-over-year basis. Sell-side analysts anticipate that Owens & Minor, Inc. will post 1.57 EPS for the current fiscal year.

Institutional Trading of Owens & Minor

Institutional investors and hedge funds have recently made changes to their positions in the business. ProShare Advisors LLC lifted its stake in Owens & Minor by 7.4% in the first quarter. ProShare Advisors LLC now owns 15,021 shares of the company's stock valued at $416,000 after buying an additional 1,029 shares during the period. Texas Permanent School Fund Corp increased its stake in Owens & Minor by 1.8% in the first quarter. Texas Permanent School Fund Corp now owns 66,953 shares of the company's stock valued at $1,855,000 after purchasing an additional 1,156 shares in the last quarter. DekaBank Deutsche Girozentrale raised its holdings in Owens & Minor by 76.6% in the second quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after purchasing an additional 1,356 shares during the period. Arizona State Retirement System boosted its position in shares of Owens & Minor by 7.7% during the second quarter. Arizona State Retirement System now owns 20,371 shares of the company's stock worth $275,000 after purchasing an additional 1,449 shares in the last quarter. Finally, Quarry LP grew its holdings in shares of Owens & Minor by 290.1% in the 2nd quarter. Quarry LP now owns 2,099 shares of the company's stock valued at $28,000 after buying an additional 1,561 shares during the period. Institutional investors own 98.04% of the company's stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.